The community of microorganisms in the mammalian gastrointestinal tract, referred to as the gut microbiota, influences host physiology and immunity. The last decade of microbiome research has provided significant advancements for the field and highlighted the importance of gut microbes to states of both health and disease. Novel molecular techniques have unraveled the tremendous diversity of intestinal symbionts that potentially influence the host, many proof-of-concept studies have demonstrated causative roles of gut microbial communities in various pathologies, and microbiomebased approaches are beginning to be implemented in the clinic for diagnostic purposes or for personalized treatments. However, several challenges for the field remain: purely descriptive reports outnumbering mechanistic studies and slow translation of experimental results obtained in animal models into the clinics. Moreover, there is a dearth of knowledge regarding how gut microbes, including novel species that have yet to be identified, impact host immune responses. The sheer complexity of the gut microbial ecosystem makes it difficult, in part, to fully understand the microbiota-host networks that regulate immunity. In the present manuscript, we review key findings on the interactions between gut microbiota members and the immune system. Because culturing microbes allows performing functional studies, we have emphasized the impact of specific taxa or communities thereof. We also highlight underlying molecular mechanisms and discuss opportunities to implement minimal microbiome-based strategies.
diseases, including allergy, asthma, multiple sclerosis, and inflammatory bowel diseases (IBD). [3] [4] [5] [6] Consequently, much interest exists in understanding the mechanisms by which members of this complex community shape host physiology and immunity.
Studies in germfree mice highlight the importance of the gut microbiota to proper immunological development-these animals have reduced numbers of immune cells present in their intestinal lamina propria and smaller Peyer's patches compared to conventionally reared mice. [7] [8] [9] [10] Systemically, they exhibit a diminished capacity for antibody production, fewer plasma cells, smaller mesenteric lymph nodes, and reduced numbers of germinal centers vs their conventional counterparts. 11 Immune maturation can be induced in germfree mice by colonization with a complex gut microbiota; however, some notable deficits and distinctions remain into adulthood depending upon the age of mice at the time of microbial exposure. [12] [13] [14] [15] [16] Indeed, early life represents a critical window for proper immune development. 17, 18 Infants are born sterile and establishment of the gut microbiota begins shortly after birth. [19] [20] [21] During this time, the mammalian host is rapidly exposed to a myriad of different microorganisms. 22, 23 The gut microbiota is quite unstable throughout the first months of life, is strongly influenced by breast-feeding, diversifies substantially with the introduction of solid food, and eventually stabilizes after the first 2 years of life. 24, 25 Such temporal variability and succession dynamics add yet another level of complexity to dissecting the interplay between the immune system and gut microbes and are beyond the scope of this review.
Instead, we will focus on the dynamic interactions between cultured members of the microbiota and host immunity. Indeed, depletion of gut microbes in conventional mice via antibiotic treatment significantly impacts the immune system-it reduces spleen size, decreases immune cell numbers and alters expression of genes regulating inflammatory responses and production of antimicrobial factors such that these animals more closely resemble germfree mice than those with a conventional microbiota. 26, 27 Cultivation of gut microbes represents an important technique for studying the relationship between this complex ecosystem and its host. Molecularbased methods represent another approach that has been reviewed many times elsewhere 28, 29 and will not be touched upon here.
Because molecular techniques allow high-throughput analysis of entire systems, they are very useful for obtaining comprehensive and integrated views of complex interactions not permitted by more reductionist approaches. In contrast, the major advantage of cultivation approaches is the ability to characterize microorganisms in great detail, perform downstream functional studies and identify specific microbial bioactive compounds and their effects on target cells. 30 Contratry to frequent introductory statements in the literature that only minor fractions of the mammalian gut microbiota can be cultured, cultivation techniques can indeed capture a substantial amount of the bacterial diversity present in the mammalian gut: a comparison of thousands of high-throughput amplicon datasets with a catalog of reference sequences from isolates revealed that 35% to 65% of microbial species in the human and mouse gut have representative strains in culture. 31 Nonetheless, there are still numerous unknown taxa to be discovered. These taxa represent a considerable pool of novel functions, some of which may have a profound impact upon the immune system.
This review compiles knowledge about the regulation of immune responses by specific members of the gut microbiota, with primary focus on studies using cultured microbes as single strains or minimal consortia to investigate specific interactions at local (gut mucosal immune system) and distant body sites. Even though culture approaches are simplistic, they provide precise knowledge that is eventually useful for proper interpretation of results generated with more comprehensive systems-oriented approaches. We acknowledge that microorganisms other than bacteria can regulate immune responses. However, the bulk of information provided here concerns bacteria as they represent the dominant members of gut ecosystems and are the subject of most reports in the literature. Furthermore, there is exhaustive literature on probiotics and their impact on the immune system. However, because most probiotic studies are based on the use of generic strains and molecular mechanisms are rarely investigated, 32, 33 we deliberately excluded probiotic studies from the present review. Finally, sophisticated in vitro systems and functional metagenomic approaches allow assessment of the impact of microbes on the immune system. 34, 35 However, because these approaches are still in their infancy and findings eventually require validation in more complex models, this review focuses primarily on data obtained in vivo.
| SINGLE STRAINS, SPECIFIC EFFECTS
Germfree mice have been used extensively to study the impact of single microorganisms on immune responses. Born and raised in the absence of living body microorganisms, these mice allow targeted manipulations of the gut microbiota and determination of the impact of specific microbial strains, including characterization of underlying molecular mechanisms. 36 Here, we highlight only a select set of experimental studies aimed at revealing the specific interactions between single bacterial species and the host, 37 some of which utilized germfree mice while others employed mouse models with a complex microbiota (more examples are described in Table 1 
| Firmicutes

| Clostridium spp.
Given the phylogenetic diversity of the Clostridium genus across its many clusters, 44 only a few major examples of species-specific interactions with the host are described here, the majority of which promote immune regulation. Conventional mice colonized with C. 
| Bacteroidetes
| Bacteroides fragilis
Although multiple members of the Bacteroides genus have been documented to impact host immune responses, our discussion here will focus specifically on the immunomodulatory properties of B. fragilis, 83 Together, these reports highlight the profoundly different interactions that can occur between the immune system and B. fragilis depending on which strain(s) are present in the host.
| Proteobacteria
| Escherichia coli
Diversity of the species E. coli represents a spectrum of host relationships that can range from mutualism to opportunistic and specialized pathogenesis. 84 Here, we will discuss only the specific examples by which select strains of commensal E. coli are known to modulate host immunity. Studies in germfree guinea pigs, chickens, and piglets were the first to describe that replicating E. coli could stimulate both mucosal and systemic immune responses. [85] [86] [87] Since then, most studies seeking to define specific interactions between the host immune sys- Figure 1 illustrates concepts for establishing these model communities based on two main approaches detailed in the paragraphs below. It is of course important to eventually test the health-modulating properties of strains under native conditions in animals colonized with endogenous complex communities. 112 However, minimal microbiomes allow detailed mechanistic investigation under controlled conditions.
| A COMMUNITY IS MORE THAN THE SUM OF ITS PARTS
| Hypothesis-driven assemblage via strain synthesis
Hypothesis-driven assemblage consists of combining known microorganisms previously cultured and characterized. The hallmark of this approach is to work with single microorganisms that must be isolated from a complex starting environment.
F I G U R E 1 From complex gut microbial community to defined experimental systems. Prerequisite for the workflows presented here is an animal model (a mouse in the present example) with a specific phenotype (eg, chronic disease with a clear measurable endpoint) or a physiological parameter of interest (eg, maturation of specific immune cell populations). The phenotype/parameter of interest can be associated with defined gut microbiota signatures and must be absent in germfree animals. Starting from a gut sample collected from an animal with the specific feature of interest, two routes of action can be followed: (A) The classical route is based on cultivation and isolation of strains (eg, microbial colonies on nutrient agar) with the aim of identifying single components of the complex ecosystem of origin that can drive the phenotype. Each isolate is characterized taxonomically and functionally and deposited in public culture collections for downstream access. Based on expert knowledge or assisted by computational methods, single strains are combined together and used to colonize germfree animals with the goal of mimicking the disease phenotype or physiological parameter of interest. (B) A second, less explored route is the selection of microbial communities with the aim of obtaining the most reduced complexity still associated with the phenotype of interest. This can be achieved via iterative association of germfree animals (circled black arrow) in the presence of selective forces (eg, special diet or antibiotics), and/or in vitro enrichment of specific microbes (eg, via selective media or simply by serial dilution) prior to colonization of germfree animals. The advantage of performing an in vitro step prior to association with mice is bulk selection of microorganisms that can indeed grow under laboratory conditions, which can substantially facilitate downstream identification of single members of the final minimal microbiome. The progress of community reduction can be monitored throughout the workflow using targeted (16S rRNA amplicon) or shotgun metagenomic sequencing. Of note, workflow B can be followed by A (dashed arrow) for detailed characterization of single community members. The new gnotobiotic models created by either approach can ultimately be used for detailed experimental testing of microbe-microbe and microbe-host interactions 
STRAIN SYNTHESIS
in vitro
Cultivation of individual species can be a substantial challenge for certain microorganisms that are highly sensitive to changes in physicochemical properties (eg, redox potential or nutrient availability).
Hence, strain selection hypotheses as generated by high-throughput sequencing are often hampered by the uncultured nature of candidate taxa. 113 So far, the assemblage of minimal bacterial consortia has been primarily driven by expert knowledge of the phylogenetic and functional diversity of the native complex ecosystem under investigation and of phylogenetically related single microorganisms that can be cultured. The altered Schaedler flora (ASF) is such a consortium that consists of eight bacterial strains originally isolated from the intestine of mice. 114 Since its establishment in the 1970s and 1980s, it has been used often as a reference defined microbiota and has therefore generated the highest number of publications describing the effects of a minimal bacterial consortium on the immune system. The ASF community has been reviewed recently in detail 115 and we have listed key studies pertaining to ASF-induced immune responses in Table 2 .
Although major immune parameters are normalized in ASF mice such that they closely resemble their conventionally raised counterparts, the limited number of strains in the ASF community and the primary rationale for their selection (to standardize mouse models prior to introduction into barrier production and limit colonization by enteric pathogens) explain why not all microbial and host-derived functions are present in ASF-bearing mice, including Th17 cell maturation, numbers of IgA+ plasmablasts, and the expression of RegIII-γ. 115 The SIHUMI microbiota represents another consortium of eight strains (originating this time from the human gut), which harbors metabolic functions not described in ASF mice, such as mucin or bilirubin conversion. when population densities are lower than those detectable by sequencing. Moreover, bacterial spatial distribution in the gut was not investigated, nor was colonization of different mouse groups with the defined complex mixture. The latter experimental aspect has a high chance to result in varying microbiota composition; one could take advantage of this interindividual variability by combining it with metabolome characterization, antigen profiling, and detailed immunophenotyping to unravel microbe-host interactions in a highly controlled manner.
Finally, one additional line of promising future research is the use of models other than mice that are better suited for translational medical research, especially pigs. 129, 130 Decades ago, studies in germfree pigs/piglets highlighted the impact of gut microbiota on the immune system. 131, 132 To the best of our knowledge, there have been very few attempts to implement minimal microbiomes in pig models. 133 Logistics associated with the maintenance of gnotobiotic pigs and limited availability of microbial strains from the pig intestine are sound explanations for this paucity of data. However, the impact of demonstrating the causal effects of specific gut microbiota members on immune regulation in animal models with better clinical relevance would match the effort required for such work.
| Functional enrichment via community reduction
Instead of following a culture-based, reductionist approach as described in the previous section, the functional enrichment workflow relies on serial reduction in starting community's complexity to obtain the most simplified consortium associated with the given phenotype of interest. This approach can include a combination of in vitro and in vivo enrichment strategies, as pictured in Figure 1 .
By focusing on target functions of the native ecosystem (eg, the ability to induce a certain disease phenotype), the major advantage of this second approach to generate minimal microbiomes is that it bypasses the major risk of not recapitulating the desired phenotype when working with single isolates or a combination thereof. However, the workload associated with multiple germfree experiments necessary for functional enrichment can rapidly become a bottleneck, and the final consortium of reduced diversity may still contain unknown taxa that complicate interpretation of results.
To the best of our knowledge, there are very few examples of functional enrichment approaches that generated defined communities.
Although not related to immune responses, a recent seminal study illustrates well the principle of in vivo community reduction. 134 The authors showed that providing a diet low in fermentable polysaccharides to mice previously colonized with a human fecal microbiota reduced the relative abundance of many taxa (as detected by sequencing), illustrating a loss of dominant microbiota members. Although this effect was reversed when a high polysaccharide diet was re-introduced to the same mice, constant feeding of the low polysaccharide diet across four generations resulted in irreversible, long-term loss of taxa.
Another example of effector strain enrichment, this time in the context of inflammation, is the in vitro enrichment of lactobacilli from the murine gut for treatment of Citrobacter rodentium colitis. These lactobacilli reduced disease severity, improved gut barrier function and decreased mRNA expression of IFN-γ and TNF in the distal colon. 135 Of note, treatment of C. rodentium infected mice with MRS alone (the medium used for in vitro enrichment) also tended to provide similar benefits and was associated with increased abundance of endogenous lactobacilli.
Perhaps the best known example of a successful community reduction approach in the context of immune modulation is the induction of Treg cells by a mixture of butyrate-producing clostridia.
136,137
The authors followed an elegant procedure with several steps of culture enrichments (eg, using chloroform) prior to inoculation into germfree recipient mice; eventually they cultivated single strains and characterized a 17-member clostridium cocktail. 138 Unfortunately, the authors did not provide full taxonomic classification of the strains that, although published, still do not have standing in the nomenclature and are not publically available. Moreover, effects of metabolic functions other than butyrate production (eg, bile acid dehydroxylation by the Clostridium scindens strain) may be worth investigating.
The minimal microbial consortia described here clearly impact host physiology-some are even documented to influence immune responses. Although the exact mechanisms underlying these hostmicrobe interactions have yet to be described, they likely involve microbial metabolites capable of modulating cellular microenvironments.
In the next section, we give examples of microbiota-derived metabolites than can influence immune responses, with a special focus on lipids.
| LIPIDS AND THEIR IMPACT ON IMMUNE RESPONSES
Lipids represent a very complex family of dietary, host, and microbial compounds. Their direct roles in regulating immunity has been reviewed elsewhere 139, 140 ; however, the impact of gut microorganisms on lipid-based modulation of the immune system is less known.
The immunoregulatory activities of short-chain fatty acids (SCFA) produced by gut bacteria via the fermentation of carbohydrates and proteins has been already studied and reviewed extensively 141,142 and will be described only briefly in the next section. The gut microbiota can also metabolize dietary lipids, cholesterol, and host-derived cholesterol metabolites such as steroids and bile acids. 
| Other lipids
Lipid-binding receptors are known to influence inflammatory responses. 140 Because the nature of these responses depends on lipid type and amount, the metabolic functions of gut bacteria such as fatty acid isomerase, 164 lipid storage, 165, 166 breakdown of triglycerides by lipase activity, 145 or conversion of cholesterol 143, 167 are likely to influence immune reactions. For instance, cholesterol has the potential to induce intestinal inflammation and chemical inhibition of cholesterol absorption was shown to diminish systemic inflammatory markers and the severity of atherosclerosis. 168, 169 Bile acids represent one family of cholesterol-derived metabolites produced by the host that are found in high concentrations in the intestine, are metabolized by gut bacteria, and influence multiple inflammatory and metabolic signaling pathways. Genetic variants in one of the main bile acid-responsive transcription factor FXR (farnesoid X receptor) have been associated with the occurrence of IBD, 170 and alterations of bile acid pools have been reported in IBD patients. 171 Mechanistic studies in mice demonstrated that interfering with bile acid signaling via FXR and TGR5 (also known as GPBAR1, G-proteincoupled bile acid receptor 1) influence TLR-dependent pathways, chemically induced colitis, and NRLP3-dependent inflammasome activation. [172] [173] [174] In vitro, bile acids regulate cytokine expression and cellular stress pathways. [175] [176] [177] In contrast to these clinically or mechanistically relevant data, there is no experimental evidence for the impact of microbial conversion of bile acids on the diversity and activity of immune cell populations. In this respect, the use of minimal microbial consortia varying in their ability to produce specific secondary bile acids will be of help. Pioneering studies based on the colonization of germfree rodents with bile acid-converting strains have been reported, 178, 179 but pathophysiological effects were not studied and the strains were not well characterized and are no longer available.
More recent work successfully established a gnotobiotic mouse model colonized with a minimal bacterial consortium producing secondary bile acids 180, 181 ; however, the strains are also not readily available and the impact on immune responses was not investigated.
| CONCLUSIONS AND OUTLOOK
Work in the 1960s first demonstrated the important influence of gut microorganisms on mouse phenotypes. 182 Today there is a renewed interest in understanding the impact of changes in microbiota composition (eg, due to animal housing) on immune responses. 65, 183 It is therefore of utmost importance to dissect the effects of specific gut bacteria on the host so we can identify the microbe-host interaction networks that shape the immune system, with the ultimate goal of manipulating these interactions for positive health outcomes. The isolation and culture of microorganisms is essential to this process as it enables working with specific taxa (as single strains or simplified communities) in downstream experiments.
Catalogs of human and mouse gut bacteria have been expanded substantially thanks to recent culture-based work. 123, 124, 126 Such strain collections represent an important foundation for controlled, mechanistic studies. Efforts to isolate and identify additional species should be continued or even intensified in the near future, especially with respect to efficient taxonomic description of novel taxa 184, 185 and to functional characterization of strains and their impact on immune functions. 40 For the latter purpose, public accessibility of strains is paramount for performing mechanistic analyses. 186 In future work, it will also be important to assess in greater detail the role of gut microorganisms other than bacteria in modulating the immune system.
Research based on the use of minimal microbiomes is now entering an accelerated phase of development. We have new opportunities to implement microbial consortia that better resemble native gut communities; such advances will also provide standardized models that are comparable between labs. Most importantly, minimal microbiomes can be used in a modular fashion-when combined with an ever-increasing availability of strains, they will facilitate determining the effects of specific taxa in the presence of endogenous microorganisms and thereby provide an important proof-of-concept in preclinical research. To support the modular design of minimal microbiomes, future work should implement novel bioinformatic approaches that infer the best possible mixtures of cultured strains (eg, based on sequencing data from dysbiotic native communities). Model communities can also be used to study host specificity of colonization and immune system maturation. Without going into detail because already discussed in detail elsewhere, 10, 126, [187] [188] [189] [190] the study of underlying molecular mechanisms using strains from various host species will also be a fascinating avenue of future research.
Although microbiome and host-gut microbe interactions research has garnered much attention in the last decade, descriptive and preclinical studies still dominate the literature and translation into human settings has been rather slow. Clostridium difficile enteric infections represent a showcase for the efficient use of minimal microbiomes in the clinic 191 ; however, this advancement likely relates to exclusion of an undesirable strain by commensals via microbe-microbe interactions and does not involve modulation of host responses as is likely needed for treatment of immune-mediated diseases. Manipulation of immune functions with microbiome-based therapeutics will likely require a more tailored approach that involves targeting specific host-microbe relationships. We may also need to intervene during the host's early life when gut communities are established and the immune system educated. 18 Finally, we should also consider that targeted microbiome modulation could also improve the efficacy of conventional medications intended to augment immune responses. 192 These and other microbiome-based interventions that modulate immunity represent an exciting new horizon for biomedical research.
